Eight Dragons Company (OTCMKTS:EDRG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 19, 2017, the Board of Directors appointed Martin Schmieg as Chief Financial (Accounting) Officer.. From 2016 to the present, Mr. Schmieg has been a director of BriaCell Therapeutics Corporation. From 2013 to the present, Mr. Schmieg has been General Manager of ClearIt, LLC. From 2010 to the present, Mr. Schmieg was founder and General Manager of Medical Technology Consulting (MSMTC). Mr. Schmieg is a graduate of LaSalle University, BS Business Administration, Major in Accounting Licensed (inactive) Certified Public Accountant.
Eight Dragons Company (OTCMKTS:EDRG) Recent Trading Information
Eight Dragons Company (OTCMKTS:EDRG) closed its last trading session up +1.00 at 9.00 with 100 shares trading hands.
Eight Dragons Company (OTCMKTS:EDRG) closed its last trading session up +1.00 at 9.00 with 100 shares trading hands.
